Lei Xi, Zhou Ning, Zhang Hao, Li Tong, Ren Fan, Zhang Bo, Li Xiongfei, Zu Lingling, Song Zuoqing, Xu Song
Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin 300052, China.
Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, China.
Cancers (Basel). 2022 Jul 4;14(13):3265. doi: 10.3390/cancers14133265.
(1) Background: Sublobar resection can be used as an alternative surgical strategy for early-stage non-small-cell lung cancer (NSCLC) patients. However, the choice between wedge resection and segmentectomy remains contentious. In this study, we investigated the optimal surgical procedure for sublobar resection in patients with NSCLC ≤ 2 cm with a lobe-specific analysis; (2) Methods: Data for patients with T1N0M0 with a diameter of ≤2 cm who had undergone sublobar resection were retrieved. Propensity score matching (PSM) was used to reduce the inherent bias, and the Kaplan-Meier method and log-rank tests were used to assess the differences in survival; (3) Results: A total of 1882 patients were identified after the PSM. Patients with NSCLC ≤ 2 cm who had undergone segmentectomy showed better survival than those who had undergone wedge resection. However, when NSCLC was ≤1 cm, there was no significant difference in OS between the two groups. This demonstrated an OS advantage of segmentectomy over wedge resection for patients with NSCLC tumors of 1-2 cm ( = 0.024). Further analysis indicated that this survival benefit was only observed in patients with right upper NSCLC of 1-2 cm, but not with NSCLC in the other four lobes; (4) Conclusions: Segmentectomy showed a greater survival benefit than wedge resection only in patients with NSCLC of 1-2 cm, particularly those with primary tumors in the right upper lobe. Therefore, we propose a lobe-specific sublobar resection strategy for early-stage NSCLC patients (tumors of 1-2 cm) who cannot tolerate lobectomy.
(1) 背景:肺叶下切除可作为早期非小细胞肺癌(NSCLC)患者的一种替代手术策略。然而,楔形切除和肺段切除之间的选择仍存在争议。在本研究中,我们通过肺叶特异性分析,探讨了直径≤2 cm的NSCLC患者肺叶下切除的最佳手术方式;(2) 方法:检索接受肺叶下切除的直径≤2 cm的T1N0M0患者的数据。采用倾向评分匹配(PSM)来减少内在偏倚,并使用Kaplan-Meier法和对数秩检验来评估生存差异;(3) 结果:PSM后共确定1882例患者。接受肺段切除的直径≤2 cm的NSCLC患者的生存率高于接受楔形切除的患者。然而,当NSCLC≤1 cm时,两组的总生存期无显著差异。这表明对于1-2 cm的NSCLC肿瘤患者,肺段切除在总生存期方面优于楔形切除(P = 0.024)。进一步分析表明,这种生存获益仅在1-2 cm的右上叶NSCLC患者中观察到,而在其他四个肺叶的NSCLC患者中未观察到;(4) 结论:仅在1-2 cm的NSCLC患者中,尤其是原发肿瘤位于右上叶的患者,肺段切除显示出比楔形切除更大的生存获益。因此,我们为不能耐受肺叶切除的早期NSCLC患者(肿瘤1-2 cm)提出一种肺叶特异性肺叶下切除策略。